C08DA Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects
ATC group of level 4 – chemical subgroup · in plain English: medicines for high blood pressure and angina
This site has the patient leaflet or the SPC of 26 medicines in this group and its subgroups.
- 22 prescription only (POM)
- 4 no longer supplied or not available
Active substance: Verapamil – all medicines with this substance, also in combinations.
Place in the ATC classification
- C Cardiovascular system drugs 1,712 medicines
- C08 Calcium channel blockers 192 medicines
- C08D Selective calcium channel blockers with direct cardiac effects 80 medicines
-
C08DA Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects 26 medicines
- C08DA01 verapamil 26 medicines
-
C08DA Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects 26 medicines
- C08D Selective calcium channel blockers with direct cardiac effects 80 medicines
- C08 Calcium channel blockers 192 medicines
2 more subgroups have no medicine with a leaflet on this site.
Medicines in the group and its subgroups
Other groups of the same level
Other names of the ATC group
- Czech: C08DA Fenylalkylaminové deriváty
- French: C08DA dérivés de la phénylalkylamine
- German: C08DA Phenylalkylamin-Derivate
- Spanish: C08DA DERIVADOS DE FENILALQUILAMINA (BLOQUEANTES CALCIO SELECTIV.)
- German: C08DA Phenylalkylamin-Derivate
- Italian: C08DA DERIVATI FENILALCHILAMINICI
- Polish: C08DA Pochodne fenyloalkiloaminy
- Turkish: C08DA Fenilalkilamin türevleri, doğrudan kardiyak etkileri olan selektif kalsiyum kanal blokerleri
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group C08DA
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
